Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Documenti analoghi

• Anthropometric Exclusions in Pediatric Clinical Trials: Implications for Medication Dosing in Malnourished Children
  di: Susan M. Abdel‐Rahman, et al.
  Pubblicazione: (2025)
• Optimizing Dosage in Pharmacotherapy—Missing the Forest for the Trees
  di: Susan M. Abdel‐Rahman, et al.
  Pubblicazione: (2024)
• Assessment of Dosing Strategies for Pediatric Drug Products
  di: Zachary L. Taylor, et al.
  Pubblicazione: (2024)
• Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020
  di: Carlton K. K. Lee, et al.
  Pubblicazione: (2025)
• Letter: Optimising Targeted Next‐Generation Sequencing for Intestinal Tuberculosis Diagnosis—Methodological Considerations
  di: Haleema Rahman
  Pubblicazione: (2025)